On February 20, the U.S. Supreme Court issued an order list that denied petitions for writ of certiorari filed in at least five intellectual property cases.
Last week, biopharmaceutical company Liquidia Technologies filed a petition for writ of certiorari with the U.S. Supreme Court to appeal a Federal Circuit ruling that affirmed induced infringement findings against Liquidia following the patent at issue being invalidated by the PTAB.
Though there is no longer an affirmative duty to seek the opinion of U.S. patent counsel after being put on notice of possible infringement of a U.S. patent .